Magic Mushrooms: Scientists Warn Against Psilocybin Use

In a study published in the Journal of Psychopharmacology, the researchers conducted a survey of nearly 2,000 people who said they encountered a past negative experience when taking psilocybin-containing “magic mushrooms”. In fact, more than 10 percent believed their worst “bad trip” could put themselves or other at risk for physical harm.
Another 2.5 percent of the respondents said that behaved aggressively after taking magic mushrooms while 2.7 percent had to seek medical help. The researchers, however, warned that the survey they conducted dud not apply to all psilocybin use because the questionnaire used wasn’t designed to study the “good trip” experiences.

Positive Experiences Too

According to PsychCentral, despite the risk of psilocybin use, most of them still reported the experience to be “worthwhile” and “meaningful”. About half of the positive responses by users of magic mushrooms claimed that it was one of the top most valuable experiences in their life.

What Are Magic Mushrooms And Psilocybin?
The U.S. Department of Justice reports that psilocybin is a hallucinogenic substance obtained from magic mushrooms which are indigenous to tropical and subtropical regions of Mexico, South America and the United States.

Though many studies have shown that psilocybin could be used to treat anxiety and depression, the use of this substance is associated with negative psychological and physical consequences. The physical effects of magic mushrooms usually take place within 20 minutes of ingestion. These could last for about 6 hours and include muscle weakness, drowsiness, lack of coordination, nausea and vomiting.

On the other hand, psychological effects of magic mushrooms include hallucinations and an inability to discern reality from fantasy. In large doses, however, panic and psychosis may occur.

Counsel & Heal

Researchers recently published the results of a large survey they conducted with magic mushroom consumers, one in which they specifically looked for details about bad trips and their lasting effects.

The survey was recently published in the Journal of Psychopharmacology, where it details the survey results of nearly 2,000 magic mushroom consumers. The researchers, who are with Johns Hopkins, specifically asked for individuals who experienced difficult or bad trips after consuming these mushrooms.

More than half of these ‘beneficial’ bad trip experiencers went on to say the difficult experience ultimately ranks among the top ten most valuable experiences they’ve ever had. Of those surveyed, 66% were from the U.S., 78% were men, 89% were white, and 51% were college educated.

There’s a note of caution among it all, though — of those surveyed, more than 7% said they had to seek treatment for ‘enduring psychological symptoms,’ three cases resulted in ‘enduring psychotic symptoms,’ and three cases resulted in an attempted suicide.

Slash Gear

Magic Mushroom: Caution Is The Word

Psilocybin, the main active ingredient in magic mushrooms, is responsible for the hallucinogenic effects. In the U.S, the magic mushroom is considered a Schedule I substance, which means that it has a high potential for abuse.

In 2014, an estimated 22.9 million people in the U.S. reported lifetime use of Psilocybin, according to the Substance Abuse and Mental Health Services Administration’s National Survey on Drug Use and Health.

Recent studies have documented a wide range of positive effects of Psilocybin on the human brain, say easing depression or anxiety. But it is equally important to inform consumers about the risks associated with its use.

According to the survey data, 39% of the respondents rated acute and enduring adverse effects of Psilocybin among the top five most challenging experiences of his/her lifetime. Eleven percent put self or others at risk of physical harm during their difficult or challenging experience (i.e., a “bad trip”). There were also three cases of attempted suicide.

But, that said the rates of adverse effects after psilocybin use have been fund to be very low relative to adverse effects associated with other psychoactive drugs, according to the survey data.

RTT News

Fighting Depression with Magic Mushroom for Cancer Patients

Psilocybin—the hallucinogenic compound in so-called “magic” mushrooms—can effectively ease cancer patients’ depression and anxiety, according to a study published in the Journal of Psychopharmacology. As many as 40% of cancer patients experience depression.

A 2014 study found users of hallucinogenic mushrooms might experience more happiness. A 2015 study linked psychedelic drugs to a reduction in thoughts of suicide, and a 2016 study found psychedelic drug use was linked to lower rates of domestic violence among men with a history of substance abuse.

Participants completed interviews and questionnaires about their mood, feelings about life, and behavior before the first session, seven hours after each dose, five weeks after each dose, and six months following the final session. At the six-month mark, 80% of participants had reductions in depression and anxiety, with 60% no longer experiencing symptoms severe enough to warrant a diagnosis

Good Therapy